Dissociation of HIV-1 from follicular dendritic cells during HAART: Mathematical analysis
- 21 December 1999
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 96 (26) , 14681-14686
- https://doi.org/10.1073/pnas.96.26.14681
Abstract
Follicular dendritic cells (FDC) provide a reservoir for HIV type 1 (HIV-1) that may reignite infection if highly active antiretroviral therapy (HAART) is withdrawn before virus on FDC is cleared. To estimate the treatment time required to eliminate HIV-1 on FDC, we develop deterministic and stochastic models for the reversible binding of HIV-1 to FDC via ligand–receptor interactions and examine the consequences of reducing the virus available for binding to FDC. Analysis of these models shows that the rate at which HIV-1 dissociates from FDC during HAART is biphasic, with an initial period of rapid decay followed by a period of slower exponential decay. The speed of the slower second stage of dissociation and the treatment time required to eradicate the FDC reservoir of HIV-1 are insensitive to the number of virions bound and their degree of attachment to FDC before treatment. In contrast, the expected time required for dissociation of an individual virion from FDC varies sensitively with the number of ligands attached to the virion that are available to interact with receptors on FDC. Although most virions may dissociate from FDC on the time scale of days to weeks, virions coupled to a higher-than-average number of ligands may persist on FDC for years. This result suggests that HAART may not be able to clear all HIV-1 trapped on FDC and that, even if clearance is possible, years of treatment will be required.Keywords
This publication has 42 references indexed in Scilit:
- Kinetics of Response in Lymphoid Tissues to Antiretroviral Therapy of HIV-1 InfectionScience, 1997
- Quantitative Image Analysis of HIV-1 Infection in Lymphoid TissueScience, 1996
- Human lymphocytes shed a soluble form of CD21 (the C3dg/Epstein‐Barr virus receptor, CR2) that binds iC3b and CD23European Journal of Immunology, 1996
- Why is it so hard to dissociate multivalent antigens from cell-surface antibodies?Immunology Today, 1996
- Follicular dendritic cells and human immunodeficiency virus infectivityNature, 1995
- A Simple Model To Predict the Effectiveness of Molecules That Block Attachment of Human Rhinoviruses and Other VirusesBiotechnology Progress, 1995
- HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of diseaseNature, 1993
- Complement Activation by gp160 Glycoprotein of HIV-1AIDS Research and Human Retroviruses, 1993
- Decreased expression of complement receptor type 2 (CR2) on neoplastic B cells of chronic lymphocytic leukaemiaClinical and Experimental Immunology, 1991
- The Follicular Dendritic Cell: Long Term Antigen Retention During ImmunityImmunological Reviews, 1980